Jump to Content
Sign in
FEATURED ARTICLES
Selected Studies
Key Research
POLICY & ADVOCACY
Current Initiatives
Public Policy
EDUCATION
Meetings & Events
Distance Learning
PARTNERSHIPS
KHI
KidneyX
KIDNEY NEWS
All Issues
PDF Archive
Detective Nephron
Fellows First
Special Sections
MORE
About
Submissions
Advanced Search
Help
Sign in
FEATURED ARTICLES
Selected Studies
Key Research
POLICY & ADVOCACY
Current Initiatives
Public Policy
EDUCATION
Meetings & Events
Distance Learning
PARTNERSHIPS
KHI
KidneyX
KIDNEY NEWS
All Issues
PDF Archive
Detective Nephron
Fellows First
Special Sections
MORE
About
Submissions
SEARCH
Advanced Search
Help
Volume/Issue:
Volume 10: Issue 3
Page:
1–2
Publication Date:
01 Mar 2018
Online Publication Date:
05 Mar 2018
Headings
ICP inhibitors and transplant patients
Immune-mediated effects
Effects beyond the kidney
Trying to keep treatment going
Figures
Export Figures
View in gallery
View in gallery
Courtesy Ala Abudayyeh
View in gallery
Figure 1.
Immune checkpoint inhibitors’ mechanism of action
Close
View raw image
View raw image
Courtesy Ala Abudayyeh
View raw image
Figure 1.
Immune checkpoint inhibitors’ mechanism of action
Next Article
Editorial Type:
Basic Article
Immune Checkpoint Inhibitors for Cancer Treatment Have Renal Side Effects
Eric Seaborg
Eric Seaborg
Search for other papers by Eric Seaborg in
Current site
Google Scholar
PubMed
Close
Volume/Issue:
Volume 10: Issue 3
Publication Date:
01 Mar 2018
Page:
1–2
Restricted access
Save
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://www.kidneynews.org/abstract/journals/kidney-news/10/3/article-p1_1.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
[18.97.14.83]
18.97.14.83
View Expanded
View Table
View Full Size